Literature DB >> 2429666

Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity.

K Nagamatsu, Y Ohno, H Ikebuchi, A Takahashi, T Terao, A Takanaka.   

Abstract

Isolated rat hepatocytes metabolized morphine to its glucuronide conjugate, morphinone-glutathione conjugate, normorphine and morphinone. Addition of morphine to the isolated hepatocytes induced a marked decrease in the level of glutathione in the cells and resulted in cell death. The formation of glutathione conjugate was correlated well with the loss of intracellular glutathione. The cytotoxicity of morphinone was higher than that of morphine. Naloxone and normorphine showed no cytotoxic effect on the cells. Naloxone inhibited the formation of morphinone-glutathione conjugate and prevented the morphine-induced cytotoxicity. Naloxone also blocked morphine-induced liver damage in vivo. In contrast, the morphinone-induced hepatotoxicity was not prevented by naloxone. It is concluded that morphine has a hepatotoxic effect, that the morphine-induced hepatotoxicity is due to its metabolic activation, and that naloxone acts as an inhibitor of an enzyme converting morphine to morphinone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429666     DOI: 10.1016/0006-2952(86)90624-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model.

Authors:  Sebnem Atici; Ismail Cinel; Leyla Cinel; Nurcan Doruk; Gulcin Eskandari; Ugur Oral
Journal:  J Biosci       Date:  2005-03       Impact factor: 1.826

2.  Lack of hepatocyte involvement in the genesis of the sinusoidal dilatation related to heroin addiction: a morphometric study.

Authors:  M S Trigueiro de Araújo; F Gérard; P Chossegros; S Guerret; J A Grimaud
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Opium use and risk of mortality from digestive diseases: a prospective cohort study.

Authors:  Masoud M Malekzadeh; Hooman Khademi; Akram Pourshams; Arash Etemadi; Hossein Poustchi; Mohammad Bagheri; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

4.  Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.

Authors:  Hooman Khademi; Reza Malekzadeh; Akram Pourshams; Elham Jafari; Rasool Salahi; Shahryar Semnani; Behrooz Abaie; Farhad Islami; Siavosh Nasseri-Moghaddam; Arash Etemadi; Graham Byrnes; Christian C Abnet; Sanford M Dawsey; Nicholas E Day; Paul D Pharoah; Paolo Boffetta; Paul Brennan; Farin Kamangar
Journal:  BMJ       Date:  2012-04-17

5.  Changes in serum biochemical factors associated with opium addiction after addiction desertion.

Authors:  Mohammad Reza Afarinesh; Tahereh Haghpanah; Kouros Divsalar; Elham Dehyadegary; Azar Shaikh-Aleslami; Majid Mahmoodi
Journal:  Addict Health       Date:  2014 Summer-Autumn

Review 6.  Opioid epidemic and liver disease.

Authors:  Elizabeth C Verna; Aaron Schluger; Robert S Brown
Journal:  JHEP Rep       Date:  2019-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.